This document is an excerpt from the EUR-Lex website
Document 62015TA0729
Case T-729/15: Judgment of the General Court of 5 February 2018 — MSD Animal Health Innovation and Intervet international v EMA (Access to documents — Regulation (EC) No 1049/2001 — Documents held by the EMA and submitted in the context of the application for marketing authorisation for the veterinary medicinal product Bravecto — Decision to grant a third party access to the documents — Exception relating to the protection of commercial interests — No general presumption of confidentiality)
Case T-729/15: Judgment of the General Court of 5 February 2018 — MSD Animal Health Innovation and Intervet international v EMA (Access to documents — Regulation (EC) No 1049/2001 — Documents held by the EMA and submitted in the context of the application for marketing authorisation for the veterinary medicinal product Bravecto — Decision to grant a third party access to the documents — Exception relating to the protection of commercial interests — No general presumption of confidentiality)
Case T-729/15: Judgment of the General Court of 5 February 2018 — MSD Animal Health Innovation and Intervet international v EMA (Access to documents — Regulation (EC) No 1049/2001 — Documents held by the EMA and submitted in the context of the application for marketing authorisation for the veterinary medicinal product Bravecto — Decision to grant a third party access to the documents — Exception relating to the protection of commercial interests — No general presumption of confidentiality)
IO C 104, 19.3.2018, p. 31–31
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
19.3.2018 |
EN |
Official Journal of the European Union |
C 104/31 |
Judgment of the General Court of 5 February 2018 — MSD Animal Health Innovation and Intervet international v EMA
(Case T-729/15) (1)
((Access to documents - Regulation (EC) No 1049/2001 - Documents held by the EMA and submitted in the context of the application for marketing authorisation for the veterinary medicinal product Bravecto - Decision to grant a third party access to the documents - Exception relating to the protection of commercial interests - No general presumption of confidentiality))
(2018/C 104/39)
Language of the case: English
Parties
Applicants: MSD Animal Health Innovation GmbH (Schwabenheim, Germany) and Intervet international BV (Boxmeer, Netherlands) (represented initially by: P. Bogaert, lawyer, B. Kelly and H. Billson, Solicitors, J. Stratford QC, and C. Thomas, Barrister, and, subsequently, by P. Bogaert, B. Kelly, J. Stratford, and C. Thomas)
Defendant: European Medicines Agency (EMA) (represented by: T. Jabłoński, A. Spina, S. Marino, A. Rusanov and N. Rampal Olmedo, acting as Agents)
Re:
Action under Article 263 TFEU for the annulment of Decision EMA/785809/2015 of the EMA of 25 November 2015, granting to a third party, pursuant to Regulation (EC) No 1049/2001 of the European Parliament and of the Council of 30 May 2001 regarding public access to European Parliament, Council and Commission documents (OJ 2001 L 145, p. 43), access to documents containing information submitted in the context of an application for marketing authorisation for the veterinary medicinal product Bravecto.
Operative part of the judgment
The Court:
|
1. |
Dismisses the action; |
|
2. |
Orders MSD Animal Health Innovation GmbH and Intervet international BV to bear their own costs and to pay those incurred by the European Medicines Agency (EMA), including those relating to the application for interim measures. |